THE European Medicines Agency (Coreper) identified a possible link between them Johnson & Johnson vaccine and rare cases of thrombosis in adults who had received the vaccine in the US, according to Reuters.
In a Twitter post, Coreper recommends adding “very rare cases of unusual thrombosis” to the list of vaccine side effects.
Johnson & Johnson “confident” about her vaccine
Meanwhile, the pharmaceutical company Johnson and Johnson (J&J) remains “absolutely confident” about its vaccine against Covid-19 and hopes to find a solution “very soon” with regulators regarding its use, which is currently suspended. in Europe and the United States due to the occurrence of rare serious blood clots, its financial director said today.
White House medical adviser Anthony Fauci said Sunday A decision in the US will be made public by Friday.
“We remain very confident” and “we hope that the balance between benefits and risks will work in our favor”, said Joseph Walk in an interview with the American network CNBC.
“We are working with regulators to make sure they have all the information they need to make their decisions,” he was quoted as saying by Agence France-Presse and the Athens News Agency.
“We expect to have a decision on how we can proceed very soon, perhaps by the end of this week, from Europe and the FDA,” said J & J’s chief financial officer. these statements on the occasion of the publication of the quarterly results of the group.
In a statement detailing the company’s financial performance, J&J did not specify the vaccine, which it sells at cost, but said it had sold vaccines for $ 100 million in the United States.
The group is also facing production problems at a plant in Baltimore, Maryland, run by Emergent BioSolutions, with a batch of vaccine doses that do not meet quality standards.
The FDA requested the suspension of production at this plant pending the completion of the inspection.
If the regulatory process “goes well, we will be able to meet all our contractual commitments (regarding the delivery of vaccines, s.s.), in the United States and around the world,” assured Joseph Walk.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
